glp-1 for insulin resistance Frontiers Glucagon-like peptide 1 (GLP-1) -
Description
The Allergan acquisition was, in part, a hedge against the Humira cliff: by the time biosimilars arrived, AbbVie had substantial revenue from non-adalimumab sources
Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for T 1 MR liver imaging
and (ii) investigate the influence of CB0313.1 on SCFA production and the taxonomic profile of the gut microbiota
& Jesseph, J
